The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
PTGF-β , a type β transforming growth factor (TGF-β) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-β signaling pathway
Open accessAbstract
Identification and characterization of p53 target genes would lead to a better understanding of p53 functions and p53-mediated signaling pathways. Two putative p53 binding sites were identified in the promoter of a gene encoding PTGF-β, a type β transforming growth factor (TGF-β) superfamily member. Gel shift assay showed that p53 bound to both sites. Luciferase-coupled transactivation assay revealed that the gene promoter was activated in a p53 dose- as well as p53 binding site-dependent manner by wild-type p53 but not by several p53 mutants. The p53 binding and transactivation of the PTGF-β promoter was enhanced by etoposide, a p53 activator, and was largely blocked by a dominant negative p53 mutant. Furthermore, expression of endogenous PTGF-β was remarkably induced by etoposide in p53-positive, but not in p53-negative, cell lines. Finally, the conditioned medium collected from PTGF-β-overexpressing cells, but not from the control cells, suppressed tumor cell growth. Growth suppression was not, however, seen in cells that lack functional TGF-β receptors or Smad4, suggesting that PTGF-β acts through the TGF-β signaling pathway. Thus, PTGF-β, a secretory protein, is a p53 target that could mediate p53-induced growth suppression in autocrinal as well as paracrinal fashions. The finding made a vertical connection between p53 and TGF-β signaling pathways in controlling cell growth and implied a potential important role of p53 in inflammation regulation via PTGF-β.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,270
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Dennler, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3091 · Cited by 1,793
A novel form of Epstein-Barr virus latency in normal B cells in vivo
Miyashita, E. M., Yang, B., Lam, K. M. C., Crawford, D. H., & Thorley-Lawson, D. A. (1995) · Cell · doi:10.1016/0092-8674(95)90513-8 · Cited by 1,593
Bax-Deficient Mice with Lymphoid Hyperplasia and Male Germ Cell Death
Knudson, C. M., Tung, K. S. K., Tourtellotte, W. G., Brown, G. A. J., & Korsmeyer, S. J. (1995) · Science · doi:10.1126/science.270.5233.96 · Cited by 1,493
mdm2 expression is induced by wild type p53 activity.
Barak, Y., Juven, T., Haffner, R., & Oren, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05678.x · Cited by 1,290
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily
Bootcov, M. R., Bauskin, A. R., Valenzuela, S. M., Moore, A. G., Bansal, M., He, X. Y., Zhang, H. P., Donnellan, M., Mahler, S., Pryor, K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11514 · Cited by 1,177
KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor gene
Wu, G. S., Burns, T. F., McDonald, E. R., Jiang, W., Meng, R., Krantz, I. D., Kao, G., Gan, D.-D., Zhou, J.-Y., Muschel, R., et al. (1997) · Nature Genetics · doi:10.1038/ng1097-141 · Cited by 1,083
Regulation of the specific DNA binding function of p53
Hupp, T. R., Meek, D. W., Midgley, C. A., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90562-q · Cited by 909
Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways
Lagna, G., Hata, A., Hemmati-Brivanlou, A., & Massagué, J. (1996) · Nature · doi:10.1038/383832a0 · Cited by 905
Induction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869
Potential Role of Human Cytomegalovirus and p53 Interaction in Coronary Restenosis
Speir, E., Modali, R., Huang, E.-S., Leon, M. B., Shawl, F., Finkel, T., & Epstein, S. E. (1994) · Science · doi:10.1126/science.8023160 · Cited by 753
DPC4 gene in various tumor types.
Schutte, M. E. M., Hruban, R. H., Hedrick, L., Cho, K. R., Nadasdy, G. M., Weinstein, C. L., Bova, G. S., Isaacs, W. B., Cairns, P., Nawroz, H., et al. (1996) · PubMed · Cited by 672
Attisano, L. (1993) · Cell · doi:10.1016/0092-8674(93)90488-c · Cited by 645
Smads and early developmental signaling by the TGFβ superfamily
Whitman, M. (1998) · Genes & Development · doi:10.1101/gad.12.16.2445 · Cited by 478
Datto, M. B., Yu, Y., & Wang, X.-F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.48.28623 · Cited by 434
Derynck, R., & Feng, X.-H. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00017-6 · Cited by 415
lavarone, A., & Massagué, J. (1997) · Nature · doi:10.1038/387417a0 · Cited by 377
Paralkar, V. M., Vail, A. L., Grasser, W. A., Brown, T. A., Xu, H., Vukicevic, S., Ke, H. Z., Qi, H., Owen, T. A., & Thompson, D. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13760 · Cited by 289
Kawabata, M., Inoue, H., Hanyu, A., Imamura, T., & Miyazono, K. (1998) · The EMBO Journal · doi:10.1093/emboj/17.14.4056 · Cited by 289
Bian, J., & Sun, Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6330 · Cited by 276
Self-citationTranscriptional Activation of the Human Glutathione Peroxidase Promoter by p53
Tan, M., Li, S., Swaroop, M., Guan, K., Oberley, L. W., & Sun, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.12061 · Cited by 253
Self-citationPLAB, a novel placental bone morphogenetic protein
Hromas, R., Hufford, M., Sutton, J., Xu, D., Li, Y., & Lu, L. (1997) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(97)00122-x · Cited by 231
Characterization of Human FAST-1, a TGFβ and Activin Signal Transducer
Zhou, S., Zawel, L., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80120-3 · Cited by 230
Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta
Lawton, L. N., Bonaldo, M. D. F., Jelenc, P. C., Qiu, L., Baumes, S. A., Marcelino, R. A., de Jesus, G. M., Wellington, S., Knowles, J. A., Warburton, D., et al. (1997) · Gene · doi:10.1016/s0378-1119(97)00485-x · Cited by 207
Frazier, M. W., He, X., Wang, J., Gu, Z., Cleveland, J. L., & Zambetti, G. P. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.3735 · Cited by 194
Transcriptional Activation of the Human Epidermal Growth Factor Receptor Promoter by Human p53
Ludes-Meyers, J. H., Subler, M. A., Shivakumar, C. V., Munoz, R. M., Jiang, P., Bigger, J. E., Brown, D. R., Deb, S. P., & Deb, S. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6009 · Cited by 182
Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells
Deb, S., Jackson, C. T., Subler, M. A., & Martin, D. W. (1992) · Journal of Virology · doi:10.1128/jvi.66.10.6164-6170.1992 · Cited by 160
SAG, a Novel Zinc RING Finger Protein That Protects Cells from Apoptosis Induced by Redox Agents
Duan, H., Wang, Y., Aviram, M., Swaroop, M., Loo, J. A., Bian, J., Tian, Y., Mueller, T., Bisgaier, C. L., & Sun, Y. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.3145 · Cited by 152
Self-citationStress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53
Komarova, E. A., Diatchenko, L. B., Rokhlin, O. W., Hill, J. E., Wang, Z. J., Krivokrysenko, V. I., Feinstein, E., & Gudkov, A. V. (1998) · Oncogene · doi:10.1038/sj.onc.1202303 · Cited by 140
The p53 Tumor Suppressor Gene Inhibits Angiogenesis by Stimulating the Production of ThrombospondinPreprint
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.053 · Cited by 123
Lin, J., Teresky, A. K., & Levine, A. J. (1995) · PubMed · Cited by 122
P53 activity is essential for normal development in Xenopus
Wallingford, J. B., Seufert, D. W., Virta, V. C., & Vize, P. D. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00333-2 · Cited by 118
Human cDNA Encoding a Novel TGF- Superfamily Protein Highly Expressed in Placenta
Yokoyama-Kobayashi, M., Saeki, M., Sekine, S., & Kato, S. (1997) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021798 · Cited by 116
Ihling, C. H., Menzel, G., Wellens, E., Mönting, J. S., Schaefer, H. E., & Zeiher, A. M. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.2218 · Cited by 107
Sun, Y., Bian, J., Wang, Y., & Jacobs, C. (1997) · Oncogene · doi:10.1038/sj.onc.1200834 · Cited by 74
Self-citationIhling, C., Haendeler, J., Menzel, G., Hess, R. D., Fraedrich, G., Schaefer, H. E., & Zeiher, A. M. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199807)185:3<303::aid-path106>3.0.co;2-p · Cited by 71
Transcriptional activation of the human S100A2 promoter by wild‐type p53
Tan, M., Heizmann, C. W., Guan, K., Schäfer, B. W., & Sun, Y. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00135-0 · Cited by 70
Self-citationMalliri, A., Yeudall, W. A., Nikolić, M., Crouch, D., Parkinson, E. K., & Ozanne, B. W. (1996) · PubMed · Cited by 68
Novel DNA binding of p53 mutants and their role in transcriptional activation.
Zhang, W., Funk, W. D., Wright, W. E., Shay, J. W., & Deisseroth, A. (1993) · PubMed · Cited by 64
Bian, J., & Sun, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14753 · Cited by 57
Self-citationSun, Y., Dong, Z., Nakamura, K., & Colburn, N. H. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.10.8344492 · Cited by 54
Self-citationSun, Y., Hildesheim, A., Li, H., Li, Y., Chen, J. Y., Cheng, Y. J., Hayes, R. B., Rothman, N., Bi, W., & Cao, Y. (1995) · PubMed · Cited by 50
Self-citationSun, Y., Nakamura, K., Hegamyer, G. A., Dong, Z., & Colburn, N. H. (1993) · Molecular Carcinogenesis · doi:10.1002/mc.2940080111 · Cited by 43
Self-citationOverexpression of p53 protein during pancreatitis
Maacke, H., Kessler, A., Schmiegel, W., et al. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.256 · Cited by 37
Krishna, M., Woda, B. A., Savas, L., Baker, S., & Banner, B. F. (1995) · PubMed · Cited by 31
Bian, J., Jacobs, C., Wang, Y., & Sun, Y. (1996) · Carcinogenesis · doi:10.1093/carcin/17.12.2559 · Cited by 21
Self-citation
Research works printed but not linked: 11
- M S Greenblatt, W P Bennett, M Hollstein, C C Harris Cancer Res 54, 4855–4878 (1994).
- 10.1002/(SICI)1098-2744(199901)24:1<25::AID-MC4>3.0.CO;2-S · doi:10.1002/(sici)1098-2744(199901)24:1<25::aid-mc4>3.0.co;2-s
- R Derynck, X H Feng Biochim Biophys Acta 1333, F105–F150 (1997).
- 10.1016/S0014-5793(99)00136-2 · doi:10.1016/s0014-5793(99)00136-2
- Y Sun, Y Pommier, N H Colburn Cancer Res 52, 1907–1915 (1992).
- Y Sun, A Hildesheim, H Li, Y Li, J Y Chen, Y J Cheng, R B Hayes, N Rothman, W F Bi, Y Cao, et al. Cancer Epidemiol Biomarkers Prev 4, 261–267 (1995).
- M Schutte, R H Hruban, L Hedrick, K R Cho, G M Nadasdy, C L Weinstein, G S Bova, W B Isaacs, P Cairns, H Nawroz, et al. Cancer Res 56, 2527–2530 (1996).
- A Malliri, W A Yeudall, M Nikolic, D H Crouch, E K Parkinson, B Ozanne Cell Growth Differ 7, 1291–1304 (1996).
- W Zhang, W D Funk, W E Wright, J W Shay, A B Deisseroth Oncogene 8, 2555–2559 (1993).
- J Lin, A K Teresky, A J Levine Oncogene 10, 2387–2390 (1995).
- M Krishna, B Woda, L Savas, S Baker, B Banner Mod Pathol 8, 654–657 (1995).
Cited by
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921
Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
Cyclooxygenase‐independent actions of cyclooxygenase inhibitors
Tegeder, I., Pfeilschifter, J., & Geisslinger, G. (2001) · The FASEB Journal · doi:10.1096/fj.01-0390rev · Cited by 747
Activation of p53 by MEG3 Non-coding RNA
Zhou, Y., Zhong, Y., Wang, Y., Zhang, X., Batista, D. L., Gejman, R., Ansell, P. J., Zhao, J., Weng, C., & Klibanski, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702029200 · Cited by 653
Self-citationKempf, T., Eden, M., Strelau, J., Naguib, M., Willenbockel, C., Tongers, J., Heineke, J., Kotlarz, D., Xu, J., Molkentin, J. D., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000202805.73038.48 · Cited by 651
Metadata
- Authors
- Tan, M., Wang, Y., Guan, K., & Sun, Y.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-01-04
- Volume
- 97
- Issue
- 1
- Pages
- 109-114
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2053042661
- Cited by
- 252
- References
- 58
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.